Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-24-000050
Filing Date
2024-10-31
Accepted
2024-10-31 16:07:46
Documents
82
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q halo-20240930.htm   iXBRL 10-Q 1418096
2 EX-31.1 ex31110qq32024.htm EX-31.1 12957
3 EX-31.2 ex31210qq32024.htm EX-31.2 12897
4 EX-32 ex3210qq32024.htm EX-32 13893
10 GRAPHIC halo-20240930_g1.jpg GRAPHIC 15840
11 GRAPHIC halo-20240930_g2.jpg GRAPHIC 1946970
12 GRAPHIC halo-20240930_g3.jpg GRAPHIC 1064423
  Complete submission text file 0001159036-24-000050.txt   15153799

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20240930.xsd EX-101.SCH 49230
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20240930_cal.xml EX-101.CAL 83574
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20240930_def.xml EX-101.DEF 262654
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20240930_lab.xml EX-101.LAB 676971
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20240930_pre.xml EX-101.PRE 471474
85 EXTRACTED XBRL INSTANCE DOCUMENT halo-20240930_htm.xml XML 1304327
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 241415277
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)